Irish Examiner1h
Research finds higher rates of HIV and Hepatitis B in Ireland than previously thought
A study to determine the extent of such blood-borne infections in the community also found that the prevalence of Hepatitis B ...
News Medical on MSN21h
Hepatitis B is a problem for a growing number of patients on immunosuppressive medications
The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation ...
Bluejay Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Brelovitug (BJT-778) for the Treatment of Chronic Hepatitis Delta
Breakthrough Therapy Designation is designed to expedite the development and review of therapies that may show significant ...
Food Safety News1d
Researchers work to develop faster, more accurate virus detection for produce
Researchers in Spain are working to develop faster, more accurate methods for detecting viruses like human norovirus and hepatitis A in fresh produce. The ...
FDA Changes Food Safety Protocol for Fresh and Frozen Berries
The FDA just announced changes to help make berries sold in the U.S. safer to eat, lowering the odds you’ll get norovirus or ...
Healio6d
People with HBV, HIV coinfection at risk for hepatitis D ‘superinfection’
Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D, which is associated with an increased ...
Food Safety News4d
FDA announces new strategy to prevent contamination of fresh and frozen berries
The FDA has developed a new strategy to prevent the contamination of fresh and frozen berries with viruses such as hepatitis ...
Which Berries Are Most Likely To Carry Viruses? A Food Safety Expert Breaks It Down Amid New FDA Rules
The Food and Drug Administration announced it was overhauling its berry safety strategy. Here's what to know, plus which are most likely to be contaminated.
The Pharma Letter1d
BRIEF—Hopes of hepatitis D breakthrough with Bluejay’s brelovitug
Privately-held US biopharma Bluejay Therapeutics has announced that its lead product candidate brelovitug—also known as BJT-778—has received US Food and Drug Administration Breakthrough Therapy ...
Monthly Prescribing Reference2d
Brelovitug Granted Breakthrough Designation for Chronic Hepatitis Delta
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).